학술논문
SD1000: High sustained viral response rate in 1361 patients with hepatitis c genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic sofosbuvir and daclatasvir: A multicenter, phase III clinical trial
Document Type
Article
Author
Merat, S.; Sharifi, A.-H.; Poustchi, H.; Gharavi, A.; Malekzadeh, Z.; Merat, D.; Jamali, R.; Sohrabpour, A.A.; Eslami, L.; Nateghi-Baygi, A.; Fattahi, B.; Nateghi-Baygi, H.; Malekzadeh, R.; Hajiani, E.; Parsi, A.; Shayesteh, A.-A.; Shayesteh, E.; Karimi, J.; Mansour-Ghanaei, F.; Fakhrieh-Asl, S.; Fattahi, M.-R.; Ahmadi, L.; Somi, M.-H.; Kalantari, H.; Ghadir, M.-R.; Hormati, A.; Sheikhesmaeili, F.; Baniasadi, N.; Sohrabi, M.; Moosavy, S.; Ziaee, M.; Zahedi, M.-J.; Mokhtare, M.; Agah, S.; Sali, S.; Sayad, B.; Afshar, B.; Bakhshipour, A.; Sharifian, A.; Amiriani, T.; Ganji, A.; Goshayeshi, L.; Norouzi, A.; Rahmani-Samani, F.; Sofian, M.; Ghezlou, M.; Valizadeh-Toosi, S.-M.; Maleki, I.; Fakheri, H.; Abna, Z.; Janbakhsh, A.; Minakari, M.; Sardarian, H.; Ghajary, A.F.; Fattahi-Abdizadeh, M.; Latifnia, M.; Roozbeh, F.; Hill, A.
Source
In: Clinical Infectious Diseases . (Clinical Infectious Diseases, 15 May 2020, 70(10):2206-2212)
Subject
Language
English
ISSN
15376591
10584838
10584838